Contrast-enhanced MRI could predict response of systemic therapy in advanced intrahepatic cholangiocarcinoma.

Ruofan ShengXiaoyong HuangKaipu JinShanshan GaoMengsu ZengDong WuGuoming Shi

Published in: European radiology (2022)

• Contrast-enhanced MRI can predict response of systemic therapy in advanced ICC. • MRI features of tumor margin, T2 homogeneity, and arterial peritumoral enhancement are related to therapeutic response. • The combined MRI-based model may help to identify appropriate therapeutic candidates.

Keyphrases

contrast enhanced
magnetic resonance imaging
diffusion weighted
magnetic resonance
computed tomography
diffusion weighted imaging
dual energy
mesenchymal stem cells